Searched for
COVAXIN TRIAL
Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trialsThe US firm in a press release said the Phase 3 trial, proposed in the IND, is designed to establish whether the immune response experience...- Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
- Bharat Biotech's Covaxin shows that it is 77.8% efficacy, gets SEC nodThe Subject Expert Committee (SEC) has reviewed Bharat Biotech’s data, and this will now be sent to the drug controller general of India fo...
- Bharat Biotech shares elaborate data of all research studies of CovaxinCovaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...
- Covaxin trials begin for children at AIIMS PatnaEarlier in the week, NITI Aayog's Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DC...
- Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
- PIL against Covaxin trial on 2-18 age group: HC seeks Centre's standCovaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is be...
- DGCI's Subject Expert Committee recommends waiving off 'clinical trial mode' from CovaxinAfter more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinic...
- Bharat Biotech approaches DCGI, seeks Covaxin's removal from 'clinical trial mode'The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...
- Covaxin in Punjab and Kerala freezers till phase-3 trial resultsSpeaking to ET, Punjab health minister Balbir Singh Sidhu said: “We don’t want to deploy the vaccine right away. Our expert panel of doctor...
- 13,000 volunteers administered 2nd dose of Covaxin in phase-3 trials: Bharat BiotechCovaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...
- Government not allowing recipient to choose vaccine, Indians not guinea pigs: CongressCongress parliamentarian Manish Tewari made a pointed query to the Union Health Minister through a tweet: “Till yesterday NDA/BJP claimed C...
- Stop Bharat Biotech's coronavirus vaccine trial in Bhopal, plead NGOs working for gas victimsIn the letters addressed to the PM and Union Health Minister Harsh Vardhan, these NGOs have also sought punishment for the "responsible par...
- Covaxin trial: Bharat Biotech completes recruitment for phase III studyHyderabad-based vaccine manufacturer Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vacci...
- After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...
- Haryana's Health Minister Anil Vij to be administered trial dose of COVID vaccine Covaxin"I will be administered a trial dose of Coronavirus vaccine #Covaxin a Bharat Biotech product Tomorrow at 11 am at Civil hospital, Ambala C...
- Phase 3 trial of Covaxin to begin in Haryana on Nov 20, Anil Vij offers to be first volunteerBharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being condu...
- Bharat Biotech looks to expand phase-III trial baseHyderabad-based Bharat Biotech is considering expanding phase-III trial of its Covid-19 vaccine candidate Covaxin by adding more sites to t...
- Bharat Biotech to begin final round of trials of Covaxin next monthThe regulator’s subject expert committee met on Tuesday and approved the phase-3 trial of the company’s indigenously developed vaccine cand...
- First part of phase-1 of Covaxin human trial completed at PGI Rohtak in HaryanaHuman trials of Covaxin, India's first vaccine candidate against coronavirus, began at PGI Rohtak on July 17. Three volunteers were adminis...
Load More
